(Q42521120)

1 November 2017

title

Possible mechanisms in the induction of vitiligo-like hypopigmentation by topical imiquimod (English)

1 reference

1 November 2017

1 reference

J Mashiah

1

1 reference

1 November 2017

S Brenner

series ordinal

2

1 reference

1 November 2017

language of work or name

1 reference

2 November 2007

1 reference

Clinical and Experimental Dermatology

1 November 2017

published in

1 reference

1 November 2017

volume

33

1 reference

1 November 2017

issue

1

1 reference

1 November 2017

page(s)

74-76

1 reference

Vitiligo-like hypopigmentation associated with imiquimod treatment of genital warts.

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02520.X

Elimination of CD4(+) T cells enhances anti-tumor effect of locally secreted interleukin-12 on B16 mouse melanoma and induces vitiligo-like coat color alteration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02520.X

Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02520.X

Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02520.X

Immunomodulation as a treatment strategy for genital herpes: review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02520.X

Imiquimod induced regression of clinically diagnosed superficial basal cell carcinoma is associated with early infiltration by CD4 T cells and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02520.X

The TLR7 agonist imiquimod enhances the anti-melanoma effects of a recombinant Listeria monocytogenes vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02520.X

Characterization of the cellular infiltrate during successful topical treatment of lentigo maligna with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2230.2007.02520.X

10.1111/J.1365-2230.2007.02520.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference